Despite Chen et al. also postulating a tumor-suppressive function in lung cancer [12], in GBM, SKI was shown to negatively regulate the TGF-β signaling pathway, leading to the promotion of tumor progression [43]. This evidence concerns the gene TGFB1 and lung cancer.